Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Tetra Bio Pharma Inc TBPMQ

Tetra Bio-Pharma Inc. is a Canada-based cannabinoid-derived drug discovery and development company. The Company has developed a pipeline of cannabinoid-based drug products for a range of medical conditions, including pain, inflammation, and oncology. The Company has a pipeline of formulations and drug delivery systems with a portfolio of assets from the early research and development phase to advanced stage clinical programs. Its products include QIXLEEF, CAUMZ, PPP004, REDUVO, and REBORN 1. QIXLEEF is a botanical therapy with a fixed dosage of tetrahydrocannabinol (THC) and cannabidiol (CBD). CAUMZ is its inhaled cannabinoid-derived drug candidate. PPP004 is a topical preparation containing either a standardized amount of CBD or a defined ratio of THC and CBD. REDUVO is a soft gel capsule used to treat chemotherapy-induced nausea and vomiting (CINV) and weight loss and severe nausea in people living with human immunodeficiency virus (HIV) infection. REBORN 1 is in phase II trial.


GREY:TBPMQ - Post by User

Post by SamV21on Nov 19, 2021 11:00am
138 Views
Post# 34145603

TD has long buy at .12 cents

TD has long buy at .12 centsYou can not go on and on making promises of profit with these make work projects, CFO knew what was coming .Go to health Canada site and look at the drugs under review , some on them have been in for over a year /18 months even some took 2 years or more. Reduvo is a narcotic with DRONABINOL Canada has banned it twice now.Other drug companies can see it is not profitable to go in that direction because of time and cost to obtain approval and the after cost risk of liability of being sued , Guy is trying to get a DIN number for an addictive narcotic, possible over dose narcotic read the side effects, he never talks about it being banned there are other drug companies working on non addictive drugs for opioid replacement, Tetra is not a drug company , they have no lab, they have no realestate , no revenue, just a Guy renting space with a laptop , pretty easy to walk when they run out of money. Reports mean nothing , it will be years before this company sees a nickel even with approval of anything.Just because you get approval companies don't see profit for years and nobody wants to buy the risk associated with dronabinol that Tetra is dreaming about.
<< Previous
Bullboard Posts
Next >>